Single-drug Chemotherapy with 5-FU and Adriamycin in Metastatic Bladder Cancer

Overview

Journal Br J Urol

Specialty Urology

Date 1981 Aug 1

PMID 7260546

Citations 9

Authors

S D Fossa

T E Gudmundsen

Affiliations

Soon will be listed here.

Abstract

Either 5-fluorouracil (5-FU) or Adriamycin was used as single-drug treatment in 10 and 15 patients respectively with measurable metastatic bladder carcinoma. In the 5-FU group there were one complete and 2 partial remissions. Six partial remissions were observed in patients treated with Adriamycin. The duration of the remissions was usually short. Gastrointestinal and haematological side effects were more pronounced in the Adriamycin group. The results are discussed in relation to other reports on cytostatic treatment of bladder carcinoma, with emphasis on general problems concerning chemotherapy of this disease.

Citing Articles

In Vitro Inhibition of Hsp90 Protein by Benzothiazoloquinazolinequinones Is Enhanced in The Presence of Ascorbate. A Preliminary In Vivo Antiproliferative Study.

Valderrama J, Rios D, Muccioli G, Buc Calderon P, Benites J Molecules. 2020; 25(4).

PMID: 32093392 PMC: 7071032. DOI: 10.3390/molecules25040953.

Prophylactic chemotherapy with intravesical instillation of adriamycin and oral administration of 5-fluorouracil after surgery for superficial bladder cancer. The Japanese Urological Cancer Research Group for Adriamycin.

Obata K, Ohashi Y, Akaza H, ISAKA S, Kagawa S, Koiso K Cancer Chemother Pharmacol. 1994; 35 Suppl:S88-92.

PMID: 7994795 DOI: 10.1007/BF00686928.

Combination chemotherapy including adriamycin for advanced transitional cell carcinoma of the urinary tract.

Kotake T, Usami M, Miki T, Kuroda M, Obata K, Osafune M Cancer Chemother Pharmacol. 1983; 11 Suppl:S38-42.

PMID: 6685580 DOI: 10.1007/BF00256716.

Early intravesical instillation of adriamycin with oral administration of 5-fluorouracil after transurethral resection for superficial bladder cancer: preliminary results.

Ueda T, Iguchi A, Sagiyama K, Osada Y, Ariyoshi A, Omoto T Cancer Chemother Pharmacol. 1987; 20 Suppl:S81-4.

PMID: 3664948 DOI: 10.1007/BF00262493.

Results of systemic chemotherapy of advanced bladder carcinomas (phase II study).

Stadie G, Moller A, Muller H, Katenkamp D, Urban H, Kob D Int Urol Nephrol. 1987; 19(1):75-9.

PMID: 3583615 DOI: 10.1007/BF02549681.